⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for salivary gland malignant mixed cell type tumor

Every month we try and update this database with for salivary gland malignant mixed cell type tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Title XELOX FOR SALIVARY GLAND CANCERSNCT00101075
Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerNCT00897793
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center
Trastuzumab in Treating Patients With Advanced Salivary Gland CancerNCT00004163
Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyNCT01156142
Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology
Title XELOX FOR SALIVARY GLAND CANCERSNCT00101075
Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute
Trastuzumab in Treating Patients With Advanced Salivary Gland CancerNCT00004163
Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During SurgeryNCT00003744
Head and Neck C...
gemcitabine
18 Years - Dana-Farber Cancer Institute
Family Quality of Life Among Families With a Member Who is a Cancer PatientNCT00544336
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
Solid Tumor
questionnaire a...
survey administ...
quality-of-life...
21 Years - Vanderbilt-Ingram Cancer Center
Title XELOX FOR SALIVARY GLAND CANCERSNCT00101075
Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute
Trastuzumab in Treating Patients With Advanced Salivary Gland CancerNCT00004163
Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During SurgeryNCT00003744
Head and Neck C...
gemcitabine
18 Years - Dana-Farber Cancer Institute
Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerNCT00851253
Head and Neck C...
stereotactic ra...
18 Years - Boston Medical Center
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyNCT01156142
Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology
Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland TumorNCT00079079
Head and Neck C...
carboplatin
cisplatin
gemcitabine hyd...
18 Years - 120 YearsCanadian Cancer Trials Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: